01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#HVO hVIVO PLC – Presentation at Jefferies Healthcare Conference November 3, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that Yamin ‘Mo’ Khan, Chief Executive Officer, will be presenting in-person at the Jefferies Global Healthcare Conference in London on 20 November 2025 at 12.30pm GMT. Alongside the presentation, the Company will also be available for one-to-one meetings. The Jefferies Global Healthcare Conference is the largest healthcare-dedicated conference in Europe and is taking place between…

Continue reading

#POLB Poolbeg Pharma PLC – Favourable Conclusion of Patent Opposition September 29, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

29 September 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces that further to its announcement on 19 September 2023, the oral opposition hearing scheduled by the European Patent Office (‘EPO’) relating to the challenge to the Company’s European patent (Immunomodulator I), has been cancelled. This favourably concludes this matter with the patent maintained as granted.   The Immunomodulator I European patent was…

Continue reading

#VELA Vela Technologies PLC investee Co. #ENSI Ensilica PLC – $2.4m contract secured with existing customer April 3, 2023 – Posted in: Vela Technologies Plc (VELA)

EnSilica, a leading mixed signal chip maker, is pleased to announce that it has secured a contract with an existing European based customer for approximately $2.4 million (‘the Contract’). This most recent award with a longstanding EnSilica customer follows a period of strong new business momentum over the last four months, with contracts announced and others secured by the Company since 30 November 2022 totalling approximately $13.5 million and underpinning current market expectations. The Contract,…

Continue reading

#VELA Vela Technologies plc – Investee Company #KNB Kanabo Group plc -Kanabo appointed to BSI Steering Group Committee October 24, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Kanabo Group plc (LSE:KNB) the pan-European medical cannabis company that focuses on developing and commercialising cannabis-derived products for medical patients and wellness consumers, has been selected as a steering group member for the development of a British Standard for CBD non-tobacco Vape products. CBD Vape products provide an alternative method to consuming CBD, which has been dominated by food and cosmetic products. Standardisation of the category is currently minimal and has historically focused on the…

Continue reading